BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 33092220)

  • 1. Microglia in Prion Diseases: Angels or Demons?
    Peggion C; Stella R; Lorenzon P; Spisni E; Bertoli A; Massimino ML
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prion proteins: physiological functions and role in neurological disorders.
    Hu W; Kieseier B; Frohman E; Eagar TN; Rosenberg RN; Hartung HP; Stüve O
    J Neurol Sci; 2008 Jan; 264(1-2):1-8. PubMed ID: 17707411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Microglial Inflammation in Prion Disease.
    Ano Y; Sakudo A; Onodera T
    Curr Issues Mol Biol; 2020; 36():1-12. PubMed ID: 31486773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglia in prion diseases.
    Aguzzi A; Zhu C
    J Clin Invest; 2017 Sep; 127(9):3230-3239. PubMed ID: 28714865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of Homeostatic Microglia Signature in Prion Diseases.
    Wang Y; Hartmann K; Thies E; Mohammadi B; Altmeppen H; Sepulveda-Falla D; Glatzel M; Krasemann S
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA-seq and network analysis reveal unique glial gene expression signatures during prion infection.
    Carroll JA; Race B; Williams K; Striebel J; Chesebro B
    Mol Brain; 2020 May; 13(1):71. PubMed ID: 32381108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cytokines and chemokines in prion infections of the central nervous system.
    Burwinkel M; Riemer C; Schwarz A; Schultz J; Neidhold S; Bamme T; Baier M
    Int J Dev Neurosci; 2004 Nov; 22(7):497-505. PubMed ID: 15465279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A neuroprotective role for microglia in prion diseases.
    Zhu C; Herrmann US; Falsig J; Abakumova I; Nuvolone M; Schwarz P; Frauenknecht K; Rushing EJ; Aguzzi A
    J Exp Med; 2016 May; 213(6):1047-59. PubMed ID: 27185853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prion channel proteins and their role in vacuolation and neurodegenerative diseases.
    Kourie JI
    Eur Biophys J; 2002 Sep; 31(5):409-16. PubMed ID: 12202918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow Cytometric Detection of PrP
    Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of prion diseases.
    Unterberger U; Voigtländer T; Budka H
    Acta Neuropathol; 2005 Jan; 109(1):32-48. PubMed ID: 15645262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement 3
    Hartmann K; Sepulveda-Falla D; Rose IVL; Madore C; Muth C; Matschke J; Butovsky O; Liddelow S; Glatzel M; Krasemann S
    Acta Neuropathol Commun; 2019 May; 7(1):83. PubMed ID: 31118110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of Apolipoprotein E is associated with exacerbation of prion pathology and promotes microglial neurodegenerative phenotype.
    Pankiewicz JE; Lizińczyk AM; Franco LA; Diaz JR; Martá-Ariza M; Sadowski MJ
    Acta Neuropathol Commun; 2021 Sep; 9(1):157. PubMed ID: 34565486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The first non-prion pathogen identified: neurotropic influenza virus.
    Sakaguchi S; Hara H
    Prion; 2022 Dec; 16(1):1-6. PubMed ID: 34978525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small is not beautiful: antagonizing functions for the prion protein PrP(C) and its homologue Dpl.
    Behrens A; Aguzzi A
    Trends Neurosci; 2002 Mar; 25(3):150-4. PubMed ID: 11852147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenic mechanisms of prion diseases.
    Unterberger U; Voigtländer T
    CNS Neurol Disord Drug Targets; 2007 Dec; 6(6):424-55. PubMed ID: 18220781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglia deficiency accelerates prion disease but does not enhance prion accumulation in the brain.
    Bradford BM; McGuire LI; Hume DA; Pridans C; Mabbott NA
    Glia; 2022 Nov; 70(11):2169-2187. PubMed ID: 35852018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroinflammation in Prion Disease.
    Li B; Chen M; Zhu C
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult human microglia secrete cytokines when exposed to neurotoxic prion protein peptide: no intermediary role for prostaglandin E2.
    Veerhuis R; Hoozemans JJ; Janssen I; Boshuizen RS; Langeveld JP; Eikelenboom P
    Brain Res; 2002 Jan; 925(2):195-203. PubMed ID: 11792368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving views in prion glycosylation: functional and pathological implications.
    Ermonval M; Mouillet-Richard S; Codogno P; Kellermann O; Botti J
    Biochimie; 2003; 85(1-2):33-45. PubMed ID: 12765773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.